Profil bibliographique

QiaoTing Luo

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

11Publications signalées

73Citations signalées

5Affiliations récentes

Institutions déclarées

Sun Yat-sen University Key Laboratory of Guangdong Province Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China South China University of Technology

Domaines associés

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentEsophageal Cancer Research and TreatmentGastric Cancer Management and Outcomes

Publications récentes

Accès ouvert 2025 articleOpenAlex

Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non‐small cell lung cancer: a prospective phase II study (GASTO‐1053)

Rui Zhou, ShiYang Zheng, Daquan Wang, Fang Dong et autres

3 citations癌症：英文版

Accès ouvert 2025 articleOpenAlex

Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial

Bo Qiu, Yuanyuan Zhao, Wenzhuo He, Wei Zeng et autres

9 citationsSignal Transduction and Targeted Therapy

Accès ouvert 2025 articleOpenAlex

Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study

FangJie Liu, QiaoTing Luo, Yu Xi, PengXin Zhang et autres

3 citationsNutrients

2025 articleOpenAlex

Safety and Efficacy of Unresectable Malignant Cardiac Tumors Treated with Concurrent Chemoradiation Therapy Using a 1.5T MR-Linac (GASTO-1078)

Shiyang Zheng, QiaoTing Luo, DaQuan Wang, Biaoshui Liu et autres

5 citationsInternational Journal of Radiation Oncology*Biology*Physics

Accès ouvert 2024 conference-abstractOpenAlex

Neoadjuvant toripalimab plus chemotherapy followed by concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (GASTO 1071).

Bo Qiu, FangJie Liu, DaQuan Wang, QiaoTing Luo et autres

1 citationJournal of Clinical Oncology

2024 conference-abstractOpenAlex

A phase II randomized trial evaluating consolidative nivolumab in locally advanced non-small cell lung cancer post neoadjuvant chemotherapy plus nivolumab and concurrent chemoradiotherapy (GASTO-1091).

Hui Liu, Bo Qiu, Yuanyuan Zhao, Wenzhuo He et autres

9 citationsJournal of Clinical Oncology

2023 conference-abstractOpenAlex

A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy.

FangJie Liu, Bo Qiu, Daquan Wang, Rui Zhou et autres

1 citationJournal of Clinical Oncology

2023 conference-abstractOpenAlex

Effect and safety of combining bevacizumab and fractionated stereotactic radiotherapy for brain metastases in patients with non-small cell lung cancer: A phase II trial.

Rui Zhou, Shiyang Zheng, Lanqing Huo, QiaoTing Luo et autres

2 citationsJournal of Clinical Oncology

Accès ouvert 2023 articleOpenAlex

Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)

Rui Zhou, Guangyu Luo, Suping Guo, Yingjia Wu et autres

7 citationsFrontiers in Oncology

Accès ouvert 2022 articleOpenAlex

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

FangJie Liu, Yingjia Wu, Jianhui Shao, Bo Qiu et autres

6 citationsFrontiers in Oncology

2022 articleOpenAlex

Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)

FangJie Liu, Bo Qiu, Xi Yu, Yifeng Luo et autres

27 citationsInternational Journal of Radiation Oncology*Biology*Physics

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.